Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as a standard of care. Nevertheless, controversial reports have been published. The aim of the present study is to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrakis, Vasilis, Rapti, Vasiliki, Akinosoglou, Karolina, Bonelis, Constantinos, Athanasiou, Kalomoira, Dimakopoulou, Vasiliki, Syrigos, Nikolaos K., Spernovasilis, Nikolaos, Trypsianis, Grigoris, Marangos, Markos, Gogos, Charalambos, Papazoglou, Dimitrios, Panagopoulos, Periklis, Poulakou, Garyfallia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611983/
https://www.ncbi.nlm.nih.gov/pubmed/36296225
http://dx.doi.org/10.3390/microorganisms10101949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611983/
https://www.ncbi.nlm.nih.gov/pubmed/36296225
http://dx.doi.org/10.3390/microorganisms10101949

Ejemplares similares